The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Liabilities of Aprea Therapeutics from 2018 to 2022 (in million U.S. dollars)
Aprea Therapeutics liabilities 2018-2022
The liabilities of Aprea Therapeutics with headquarters in the United States amounted to ** U.S. dollars in 2022. The reported fiscal year ends on December 31.
Compared to 2018, this marks a decrease of approximately *** U.S. dollars. The trend from 2018 to 2022 shows, however, that this decrease did not happen continuously.
Compared to 2018, this marks a decrease of approximately *** U.S. dollars. The trend from 2018 to 2022 shows, however, that this decrease did not happen continuously.
Log in or register to access precise data.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Applied Therapeutics liabilities 2020-2024
- Premium Statistic Apellis Pharmaceuticals liabilities 2021-2025
- Premium Statistic Apexigen, Inc. liabilities 2020-2022
- Premium Statistic Annovis Bio liabilities 2021-2025
- Premium Statistic Annexon liabilities 2021-2025
- Premium Statistic Anixa Biosciences liabilities 2021-2025
- Premium Statistic Anebulo Pharmaceuticals liabilities 2021-2025
- Premium Statistic Applied Molecular Transport Inc. liabilities 2019-2022
- Premium Statistic Ampio Pharmaceuticals liabilities 2019-2023
- Premium Statistic Amylyx Pharmaceuticals liabilities 2021-2025
About the region
10
- Premium Statistic Applied Digital liabilities 2021-2025
- Premium Statistic Appgate liabilities 2013-2022
- Premium Statistic Apollo Endosurgery, Inc. liabilities 2018-2022
- Premium Statistic Apptech Payments liabilities 2021-2025
- Premium Statistic Angel Oak Mortgage Reit, Inc. liabilities 2021-2025
- Premium Statistic Arogo Capital Acquisition liabilities 2021-2024
- Premium Statistic American Well liabilities 2021-2025
- Premium Statistic Amprius Technologies liabilities 2021-2025
- Premium Statistic Amplitude liabilities 2021-2025
- Premium Statistic Amplitech Group, Inc. liabilities 2021-2025
Selected statistics
10
- Premium Statistic Ascend Wellness Holdings liabilities 2021-2025
- Premium Statistic Ani Pharmaceuticals liabilities 2021-2025
- Premium Statistic Acadia Pharmaceuticals liabilities 2021-2025
- Premium Statistic Zydus Lifesciences Limited liabilities 2021-2025
- Premium Statistic Torrent Pharmaceuticals Limited liabilities 2021-2025
- Premium Statistic Piramal Pharma Limited liabilities 2021-2025
- Premium Statistic Mankind Pharma Limited liabilities 2021-2025
- Premium Statistic Lupin Limited liabilities 2021-2025
- Premium Statistic Jubilant Pharmova Limited liabilities 2021-2025
- Premium Statistic Ipca Laboratories Limited liabilities 2021-2025
Other regions
10
- Premium Statistic Zee Entertainment Enterprises Limited liabilities 2021-2025
- Premium Statistic Wipro Limited liabilities 2021-2025
- Premium Statistic Zydus Wellness Limited liabilities 2021-2025
- Premium Statistic Zuari Industries Limited liabilities 2021-2025
- Premium Statistic Zuari Agro Chemicals Limited liabilities 2021-2025
- Premium Statistic ZF Commercial Vehicle Control Systems India Limited liabilities 2021-2025
- Premium Statistic West Coast Paper Mills Limited liabilities 2021-2025
- Premium Statistic Wockhardt Limited liabilities 2021-2025
- Premium Statistic Wheels India Limited liabilities 2021-2025
- Premium Statistic Westlife Foodworld Limited liabilities 2021-2025
Related statistics
10
- Premium Statistic Applied Minerals liabilities 2017-2021
- Premium Statistic Artificial Intelligence Tech liabilities 2020-2024
- Premium Statistic Arteris liabilities 2021-2025
- Premium Statistic Angiogenex, Inc. liabilities 2017-2018
- Premium Statistic Arcellx liabilities 2021-2025
- Premium Statistic Antiaging Quantum Living liabilities 2020-2024
- Premium Statistic Associated Capital Group liabilities 2020-2024
- Premium Statistic Ameris Bancorp liabilities 2021-2025
- Premium Statistic Apple liabilities 2021-2025
- Premium Statistic Arlington Asset Investment Corp. liabilities 2018-2022
Further Content: You might find this interesting as well
U.S. Securities and Exchange Commission. (July 8, 2026). Liabilities of Aprea Therapeutics from 2018 to 2022 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 16, 2026, from /forecasts/1511921/aprea-therapeutics-liabilities/
U.S. Securities and Exchange Commission. "Liabilities of Aprea Therapeutics from 2018 to 2022 (in million U.S. dollars)." Chart. July 8, 2026. ÌÇÐÄÆÆ½â°æ. Accessed July 16, 2026. /forecasts/1511921/aprea-therapeutics-liabilities/
U.S. Securities and Exchange Commission. (2026). Liabilities of Aprea Therapeutics from 2018 to 2022 (in million U.S. dollars). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 16, 2026. /forecasts/1511921/aprea-therapeutics-liabilities/
U.S. Securities and Exchange Commission. "Liabilities of Aprea Therapeutics from 2018 to 2022 (in Million U.S. Dollars)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 8 Jul 2026, /forecasts/1511921/aprea-therapeutics-liabilities/
U.S. Securities and Exchange Commission, Liabilities of Aprea Therapeutics from 2018 to 2022 (in million U.S. dollars) ÌÇÐÄÆÆ½â°æ, /forecasts/1511921/aprea-therapeutics-liabilities/ (last visited July 16, 2026)
Liabilities of Aprea Therapeutics from 2018 to 2022 (in million U.S. dollars) [Graph], U.S. Securities and Exchange Commission, July 8, 2026. [Online]. Available: /forecasts/1511921/aprea-therapeutics-liabilities/
Advertisement









